I am glad to share the news that CAR T-Cell Therapy
CAR
T-Cell Therapy for Mesothelioma Proving Effective in Clinical Trial
“Dr. Prasad Adusumilli at Memorial Sloan
Kettering Cancer Center believes novel CAR T-cell therapy will be
part of future, standard-of-care treatment for malignant pleural mesothelioma.
The therapy involves the
laboratory reprogramming of a patient’s T cells — a type of white blood cell —
to attack the cancer by targeting mesothelin, a surface protein.
CAR T-cell therapy is a
form of immunotherapy that could extend mesothelioma survival significantly.
“That’s my goal. That’s
what we’ve been working toward for many years,” Adusumilli told The
Mesothelioma Center at Asbestos.com. “And from what we’re seeing now, I’m
optimistic.””
No comments:
Post a Comment